Predictors of health-related quality of life in patients with idiopathic pulmonary arterial hypertension

Journal of Hospice and Palliative Nursing

Volumn 14, Issue 4, 2012, Pages 283-292

  Matura, Lea Ann ^a   McDonough, Annette ^b   Carroll, Diane L ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

health status; idiopathic pulmonary arterial hypertension; quality of life

Indexed keywords

EID: 84862059000     PISSN: 15222179     EISSN: 15390705     Source Type: Journal    
DOI: 10.1097/NJH.0b013e3182496c04     Document Type: Article

References (36)

1. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54:S43-S54.
2. Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry. Chest. 2010;137:376-387.
3. McDonough A, Matura LA, Carroll DL. Symptom experience of pulmonary arterial hypertension patients. Clin Nurs Res. 2011;20: 120-134.
4. Flattery M, Pinson J, Savage L, Salyer J. Living with pulmonary artery hypertension: patients' experiences. Heart Lung. 2005; 34:99-107. (Pubitemid 40343085)
5. Thenappan T, Shah SJ, Rich S, Tian L, Archer SL, Gomberg-Maitland M. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation. Eur Respir J. 2010;35:1079-1087.
6. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2009;30:2493-2537.
7. Rumsfeld JS. Health status and clinical practice. Circulation. 2002;106:5-7.
8. Covinsky KE, Wu AW, Landefeld CS, et al. Health status versus quality of life in older patients: does the distinction matter? Am J Med. 1999;106:435-440. (Pubitemid 29190597)
9. Chen H, Taichman DB, Doyle RL. Health-related 1uality of life and patient-reported outcomes in pulmonary arterial hypertension. Proc Am Thorac Soc. 2008;5:623-630. (Pubitemid 352031535)
10. Revicki D, Gnanasakthy A, Weinfurt K. Documenting the rationale and psychometric characteristics of patient reported outcomes for labeling and promotional claims: the PRO evidence dossier. Qual Life Res. 2007;16:717-723. (Pubitemid 46474951)
11. Mereles D, Ehlken N, Kreuscher S, et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation. 2006;114:1482-1489. (Pubitemid 44527003)
12. Keogh AM, McNeil KD, Wlodarczyk J, Gabbay E, Williams TJ. Quality of life in pulmonary arterial hypertension: improvement and maintenance with bosentan. J Heart Lung Transplant. 2007;26:181-187. (Pubitemid 46136035)
13. Affuso F, Palmieri EA, Di Conza P, Guardasole V, Fazio S. Tadalafil improves quality of life and exercise tolerance in idiopathic pulmonary arterial hypertension. Int J Cardiol. 2006; 108:429-431. (Pubitemid 43339824)
14. Hoeper MM, Leuchte H, Halank M, et al. Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension. Eur Respir J. 2006;28:691-694. (Pubitemid 46331988)
15. Simonneau G, Rubin LJ, Galiè N, et al. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension. Ann Intern Med. 2008;149: 521-530.
16. Shafazand S, Goldstein MK, Doyle RL, Hlatky MA, Gould MK. Health-related quality of life in patients with pulmonary arterial hypertension. Chest. 2004;126:1452-1459. (Pubitemid 39525016)
17. Taichman D, Shin J, Hud L, et al. Health-related quality of life in patients with pulmonary arterial hypertension. Respir Res. 2005;6:92.
18. Zlupko M, Harhay MO, Gallop R, et al. Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension. Respir Med. 2008;102:1431-1438.
19. White J, Hopkins R, Glissmeyer E, Kitterman N, Elliott CG. Cognitive, emotional, and quality of life outcomes in patients with pulmonary arterial hypertension. Respir Res. 2006;7:55.
20. Löwe B, Gräfe K, Ufer C, et al. Anxiety and depression in patients with pulmonary hypertension. Psychosom Med. 2004; 66:831-836. (Pubitemid 39552865)
21. McCollister DH, Beutz M, McLaughlin V, et al. Depressive symptoms in pulmonary arterial hypertension: prevalence and association with functional status. Psychosomatics. 2010;51: 339-3398.
22. Chua R, Keogh A, Byth K, O'Loughlin A. Comparison and validation of three measures of quality of life in patients with pulmonary hypertension. Intern Med J. 2006;36:705-710. (Pubitemid 44563431)
23. Chow S, Pope J, Mehta S. Lack of correlation of the health assessment questionnaire disability index with lung parameters in systemic sclerosis associated pulmonary arterial hypertension. Clin Exp Rheumatol. 2008;26:1012-1017.
24. Ware J, Kosinski N, Keller SK. SF-36 Physical and Mental Summary Scales: A User's Guide Manual. Boston, MA: New England Medical Center; 1994.
25. Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. Br Med J. 1992;305:160-164.
26. McKenna S, Doughty N, Meads D, Doward L, Pepke-Zaba J. The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension. Qual Life Res. 2006;15:103-115. (Pubitemid 43097591)
27. Gomberg-Maitland M, Thenappan T, Rizvi K, Chandra S, Meads D, McKenna S. United States validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR). J Heart Lung Transplant. 2008;27:124-130.
28. McNair DM, Loir M, Droppleman LF. Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service; 1971.
29. Matura LA, Carroll DL. Human responses to pulmonary arterial hypertension: review of the literature. J Cardiovasc Nurs. 2010;25: 420-427.
30. Blalock AC, McDaniel JS, Farber EW. Effect of employment on quality of life and psychological functioning in patients with HIV/AIDS. Psychosomatics. 2002;43:400-404.
31. Blake C, Codd M, Cassidy A, O'Meara Y. Physical function, employment and quality of life in end-stage renal disease. J Nephrol. 2000;13:142-149. (Pubitemid 30260883)
32. Cullen D, Stiffler D. Long-term oxygen therapy: review from the patients' perspective. Chron Respir Dis. 2009;6:141-147.
33. Paran E, Anson O, Neumann L. The effects of diuretics on quality of life of hypertensive patients. J Hum Hypertens. 1996;(suppl 3): 147-152.
34. Centers for Medicare & Medicaid Services. Medicare and Med-icaid Programs: Hospice Conditions of Participation. Baltimore, MD: CMS; 2008.
35. Doran AK, Ivy DD, Barst RJ, Hill N, Murali S, Benza RL. Guidelines for the preventionof central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension. Int J Clin Pract (Suppl). 2008;62:5-9. (Pubitemid 352000590)
36. Qaseem A, Snow V, Shekelle P, et al. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008;148: 141-146. (Pubitemid 351651556)